Rosen JM - Search Results

1

Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.

Zahnow CA, Younes P, Laucirica R, Rosen JM. Zahnow CA, et al. Among authors: rosen jm. J Natl Cancer Inst. 1997 Dec 17;89(24):1887-91. doi: 10.1093/jnci/89.24.1887. J Natl Cancer Inst. 1997. PMID: 9414177

2

Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression.

Raught B, Liao WS, Rosen JM. Raught B, et al. Among authors: rosen jm. Mol Endocrinol. 1995 Sep;9(9):1223-32. doi: 10.1210/mend.9.9.7491114. Mol Endocrinol. 1995. PMID: 7491114

3

Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.

Raught B, Gingras AC, James A, Medina D, Sonenberg N, Rosen JM. Raught B, et al. Among authors: rosen jm. Cancer Res. 1996 Oct 1;56(19):4382-6. Cancer Res. 1996. PMID: 8813130

4

Composite response elements mediate hormonal and developmental regulation of milk protein gene expression.

Rosen JM, Zahnow C, Kazansky A, Raught B. Rosen JM, et al. Biochem Soc Symp. 1998;63:101-13. Biochem Soc Symp. 1998. PMID: 9513715 Review.

5

A transgenic mouse model for mammary carcinogenesis.

Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM. Li B, et al. Among authors: rosen jm. Oncogene. 1998 Feb 26;16(8):997-1007. doi: 10.1038/sj.onc.1201621. Oncogene. 1998. PMID: 9519874

6

C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland.

Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM. Seagroves TN, et al. Among authors: rosen jm. Genes Dev. 1998 Jun 15;12(12):1917-28. doi: 10.1101/gad.12.12.1917. Genes Dev. 1998. PMID: 9637692 Free PMC article.

7

Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.

Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM. Hadsell DL, et al. Among authors: rosen jm. Oncogene. 2000 Feb 17;19(7):889-98. doi: 10.1038/sj.onc.1203386. Oncogene. 2000. PMID: 10702797

8

C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development.

Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM. Seagroves TN, et al. Among authors: rosen jm. Mol Endocrinol. 2000 Mar;14(3):359-68. doi: 10.1210/mend.14.3.0434. Mol Endocrinol. 2000. PMID: 10707954

9

P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer.

Chakravarty G, Roy D, Gonzales M, Gay J, Contreras A, Rosen JM. Chakravarty G, et al. Among authors: rosen jm. Cell Growth Differ. 2000 Jul;11(7):343-54. Cell Growth Differ. 2000. PMID: 10939588

10

Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor.

Wyszomierski SL, Rosen JM. Wyszomierski SL, et al. Among authors: rosen jm. Mol Endocrinol. 2001 Feb;15(2):228-40. doi: 10.1210/mend.15.2.0597. Mol Endocrinol. 2001. PMID: 11158330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters